AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
ASSESSMENT OF THE PREDICTIVE POWER OF GENOTYPES FOR THE IN-VIVO CATALYTIC FUNCTION OF CYP2D6 IN A GERMAN POPULATION
Authors: GRIESE EU ZANGER UM BRUDERMANNS U GAEDIGK A MIKUS G MORIKE K STUVEN T EICHELBAUM M
Citation: Eu. Griese et al., ASSESSMENT OF THE PREDICTIVE POWER OF GENOTYPES FOR THE IN-VIVO CATALYTIC FUNCTION OF CYP2D6 IN A GERMAN POPULATION, Pharmacogenetics, 8(1), 1998, pp. 15-26
VARIABILITY IN THE FREQUENCY OF CYTOCHROME P450-2D6 (CYP2D6) DEFICIENCY
Authors: MORIKE K PLATTEN HP MIKUS G KLOTZ U
Citation: K. Morike et al., VARIABILITY IN THE FREQUENCY OF CYTOCHROME P450-2D6 (CYP2D6) DEFICIENCY, British journal of clinical pharmacology, 46(1), 1998, pp. 87-87
SAME INCIDENCE OF ADVERSE DRUG EVENTS AFTER CODEINE ADMINISTRATION IRRESPECTIVE OF THE GENETICALLY-DETERMINED DIFFERENCES IN MORPHINE FORMATION
Authors: ECKHARDT K LI SX AMMON S SCHANZLE G MIKUS G EICHELBAUM M
Citation: K. Eckhardt et al., SAME INCIDENCE OF ADVERSE DRUG EVENTS AFTER CODEINE ADMINISTRATION IRRESPECTIVE OF THE GENETICALLY-DETERMINED DIFFERENCES IN MORPHINE FORMATION, Pain, 76(1-2), 1998, pp. 27-33
DRUG-THERAPY INFORMATION - A SERVICE PROVIDED BY CLINICAL PHARMACOLOGISTS FOR PHYSICIANS IN PRIVATE-PRACTICE AND HOSPITALS
Authors: MORIKE K BOESEN N MIKUS G SCHWAB M
Citation: K. Morike et al., DRUG-THERAPY INFORMATION - A SERVICE PROVIDED BY CLINICAL PHARMACOLOGISTS FOR PHYSICIANS IN PRIVATE-PRACTICE AND HOSPITALS, European Journal of Clinical Pharmacology, 54(7), 1998, pp. 573-574
PHARMACOKINETICS OF DIHYDROCODEINE AND DIHYDROMORPHINE AFTER SINGLE-DOSE AND DURING STEADY-STATE OF 3 DIFFERENT DOSES OF DIHYDROCODEINE IN CYP2D6 EXTENSIVE METABOLIZERS
Authors: AMMON S HOFMANN U MIKUS G
Citation: S. Ammon et al., PHARMACOKINETICS OF DIHYDROCODEINE AND DIHYDROMORPHINE AFTER SINGLE-DOSE AND DURING STEADY-STATE OF 3 DIFFERENT DOSES OF DIHYDROCODEINE IN CYP2D6 EXTENSIVE METABOLIZERS, Naunyn-Schmiedeberg's archives of pharmacology, 358(4), 1998, pp. 5-5
HEROIN SUBSTITUTION THERAPY - PHARMACOKINETICS OF DIHYDROCODEINE
Authors: MIKUS G ULMER A MORIKE K HOFMANN U
Citation: G. Mikus et al., HEROIN SUBSTITUTION THERAPY - PHARMACOKINETICS OF DIHYDROCODEINE, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4728-4728
A RAPID, HIGHLY SENSITIVE HPLC MASS-SPECTROMETRIC METHOD FOR THE DETERMINATION OF MORPHINE AND ITS METABOLITES - APPLICATION TO PHARMACOKINETIC STUDIES
Authors: SCHANZLE G LI S FROMM MF ECKHARDT K HOFMANN U MIKUS G EICHELBAUM M
Citation: G. Schanzle et al., A RAPID, HIGHLY SENSITIVE HPLC MASS-SPECTROMETRIC METHOD FOR THE DETERMINATION OF MORPHINE AND ITS METABOLITES - APPLICATION TO PHARMACOKINETIC STUDIES, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4816-4816
IS THERE AN IMPACT OF CYP2D6 GENOTYPE ON THE TOXICITY OF ECSTASY AND RELATED DESIGNER DRUGS
Authors: SCHWAB M GRIESE U HERMLE L GOUZOULIS E ZANGER U MIKUS G
Citation: M. Schwab et al., IS THERE AN IMPACT OF CYP2D6 GENOTYPE ON THE TOXICITY OF ECSTASY AND RELATED DESIGNER DRUGS, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 639-639
PHARMACOKINETICS AND PHARMACODYNAMICS OF PLACEBO-CONTROLLED SINGLE RISING ORAL DOSES OF VERAPAMIL, S-VERAPAMIL AND R-VERAPAMIL
Authors: ECKERT S MIKUS G HOFMANN U EICHELBAUM M
Citation: S. Eckert et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF PLACEBO-CONTROLLED SINGLE RISING ORAL DOSES OF VERAPAMIL, S-VERAPAMIL AND R-VERAPAMIL, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 667-667
IN-VITRO O-DEMETHYLATION OF CODEINE-6-GLUCURONIDE BY CYP2D6
Authors: SCHANZLE G ZANGER U HOFMANN U MIKUS G
Citation: G. Schanzle et al., IN-VITRO O-DEMETHYLATION OF CODEINE-6-GLUCURONIDE BY CYP2D6, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 682-682
PHARMACOKINETICS AND THE PHARMACODYNAMIC ACTION OF MIDAZOLAM IN YOUNGAND ELDERLY PATIENTS UNDERGOING TOOTH EXTRACTION
Authors: PLATTEN HP SCHWEIZER E DILGER K MIKUS G KLOTZ U
Citation: Hp. Platten et al., PHARMACOKINETICS AND THE PHARMACODYNAMIC ACTION OF MIDAZOLAM IN YOUNGAND ELDERLY PATIENTS UNDERGOING TOOTH EXTRACTION, Clinical pharmacology and therapeutics, 63(5), 1998, pp. 552-560
LOSS OF ANALGESIC EFFECT OF MORPHINE DUE COADMINISTRATION OF RIFAMPIN
Authors: FROMM MF ECKHARDT K LI SX SCHANZLE G HOFMANN U MIKUS G EICHELBAUM M
Citation: Mf. Fromm et al., LOSS OF ANALGESIC EFFECT OF MORPHINE DUE COADMINISTRATION OF RIFAMPIN, Pain, 72(1-2), 1997, pp. 261-267
CHRONOPHARMACOKINETIC AND CHRONOPHARMACO-DYNAMIC INVESTIGATION OF A NEW VERAPAMIL MODIFIED RELEASE FORMULATION
Authors: ECKHARDT K DILGER K EICHELBAUM M KUCHER K MIKUS G
Citation: K. Eckhardt et al., CHRONOPHARMACOKINETIC AND CHRONOPHARMACO-DYNAMIC INVESTIGATION OF A NEW VERAPAMIL MODIFIED RELEASE FORMULATION, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 445-445
A DRUG-THERAPY INFORMATION-SERVICE FOR PRACTITIONERS IN NORTHERN WURTTEMBERG - FIRST EXPERIENCES WITH A HOTLINE
Authors: MORIKE K SCHWAB M MIKUS G BOSEN N EICHELBAUM M
Citation: K. Morike et al., A DRUG-THERAPY INFORMATION-SERVICE FOR PRACTITIONERS IN NORTHERN WURTTEMBERG - FIRST EXPERIENCES WITH A HOTLINE, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 447-447
CATALYTIC IN-VIVO FUNCTION OF CYP2D6 IN RELATION TO THE GENOTYPE
Authors: GRIESE EU GAEDIGK A",MORIKE,"MIKUS G ZANGER U EICHELBAUM M
Citation: Eu. Griese et al., CATALYTIC IN-VIVO FUNCTION OF CYP2D6 IN RELATION TO THE GENOTYPE, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 458-458
PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ENANTIOMERS OF GALLOPAMIL
Authors: GROSS AS MIKUS G RATGE D WISSER H EICHELBAUM M
Citation: As. Gross et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ENANTIOMERS OF GALLOPAMIL, The Journal of pharmacology and experimental therapeutics, 281(3), 1997, pp. 1102-1112
EFFECT OF CODEINE ON GASTROINTESTINAL MOTILITY IN RELATION TO CYP2D6 PHENOTYPE
Authors: MIKUS G TRAUSCH B RODEWALD C HOFMANN U RICHTER K GRAMATTE T EICHELBAUM M
Citation: G. Mikus et al., EFFECT OF CODEINE ON GASTROINTESTINAL MOTILITY IN RELATION TO CYP2D6 PHENOTYPE, Clinical pharmacology and therapeutics, 61(4), 1997, pp. 459-466
IMPACT OF QUINIDINE ON PLASMA AND CEREBROSPINAL-FLUID CONCENTRATIONS OF CODEINE AND MORPHINE AFTER CODEINE INTAKE
Authors: SINDRUP SH HOFMANN U ASMUSSEN J MIKUS G BROSEN K NIELSEN F INGWERSEN SH CHRISTENSEN CB
Citation: Sh. Sindrup et al., IMPACT OF QUINIDINE ON PLASMA AND CEREBROSPINAL-FLUID CONCENTRATIONS OF CODEINE AND MORPHINE AFTER CODEINE INTAKE, European Journal of Clinical Pharmacology, 49(6), 1996, pp. 503-509
THE INFLUENCE OF CYP2D6 POLYMORPHISM AND QUINIDINE ON THE DISPOSITIONAND ANTITUSSIVE EFFECT OF DEXTROMETHORPHAN IN HUMANS
Authors: CAPON DA BOCHNER F KERRY N MIKUS G DANZ C SOMOGYI AA
Citation: Da. Capon et al., THE INFLUENCE OF CYP2D6 POLYMORPHISM AND QUINIDINE ON THE DISPOSITIONAND ANTITUSSIVE EFFECT OF DEXTROMETHORPHAN IN HUMANS, Clinical pharmacology and therapeutics, 60(3), 1996, pp. 295-307
SIMULTANEOUS DETERMINATION OF DIHYDROCODEINE AND DIHYDROMORPHINE IN SERUM BY GAS-CHROMATOGRAPHY TANDEM MASS-SPECTROMETRY
Authors: HOFMANN U FROMM MF JOHNSON S MIKUS G
Citation: U. Hofmann et al., SIMULTANEOUS DETERMINATION OF DIHYDROCODEINE AND DIHYDROMORPHINE IN SERUM BY GAS-CHROMATOGRAPHY TANDEM MASS-SPECTROMETRY, Journal of chromatography B. Biomedical applications, 663(1), 1995, pp. 59-65
ZOFENOPRIL AFTER ANTERIOR MYOCARDIAL-INFARCTION
Authors: MORIKE K MIKUS G
Citation: K. Morike et G. Mikus, ZOFENOPRIL AFTER ANTERIOR MYOCARDIAL-INFARCTION, The New England journal of medicine, 332(25), 1995, pp. 1715-1715
DIHYDROCODEINE - A NEW OPIOID SUBSTRATE FOR THE POLYMORPHIC CYP2D6 INHUMANS
Authors: FROMM MF HOFMANN U GRIESE EU MIKUS G
Citation: Mf. Fromm et al., DIHYDROCODEINE - A NEW OPIOID SUBSTRATE FOR THE POLYMORPHIC CYP2D6 INHUMANS, Clinical pharmacology and therapeutics, 58(4), 1995, pp. 374-382
STEREOSELECTIVITY IN CARDIOVASCULAR AND BIOCHEMICAL-ACTION OF CALCIUM-ANTAGONISTS - STUDIES WITH THE ENANTIOMERS OF THE DIHYDROPYRIDINE NITRENDIPINE
Authors: MIKUS G MAST V RATGE D WISSER H EICHELBAUM M
Citation: G. Mikus et al., STEREOSELECTIVITY IN CARDIOVASCULAR AND BIOCHEMICAL-ACTION OF CALCIUM-ANTAGONISTS - STUDIES WITH THE ENANTIOMERS OF THE DIHYDROPYRIDINE NITRENDIPINE, Clinical pharmacology and therapeutics, 57(1), 1995, pp. 52-61
THE ROLE OF CYP2D6 IN PRIMARY AND SECONDARY OXIDATIVE-METABOLISM OF DEXTROMETHORPHAN - IN-VITRO STUDIES USING HUMAN LIVER-MICROSOMES
Authors: KERRY NL SOMOGYI AA BOCHNER F MIKUS G
Citation: Nl. Kerry et al., THE ROLE OF CYP2D6 IN PRIMARY AND SECONDARY OXIDATIVE-METABOLISM OF DEXTROMETHORPHAN - IN-VITRO STUDIES USING HUMAN LIVER-MICROSOMES, British journal of clinical pharmacology, 38(3), 1994, pp. 243-248
THE INFLUENCE OF PHARMACOGENETICS ON OPIOID ANALGESIA - STUDIES WITH CODEINE AND OXYCODONE IN THE SPRAGUE-DAWLEY DARK AGOUTI RAT MODEL-2
Authors: CLEARY J MIKUS G SOMOGYI A BOCHNER F
Citation: J. Cleary et al., THE INFLUENCE OF PHARMACOGENETICS ON OPIOID ANALGESIA - STUDIES WITH CODEINE AND OXYCODONE IN THE SPRAGUE-DAWLEY DARK AGOUTI RAT MODEL-2, The Journal of pharmacology and experimental therapeutics, 271(3), 1994, pp. 1528-1534
Risultati: 1-25 | 26-27